Drugs / ProCervix
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01957878 | Dec 2013 → Oct 2016 | human papilloma virus infection, viral sexually transmitted disease | Genticel | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ProCervix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01957878 ↗ |
| Modality | Vaccine | “The strategy of therapeutic vaccination with ProCervix is to activate and enhance the patient's cellular immune response to HPV .” NCT01957878 ↗ |